title: [Immune replacement therapy in RS infection].
abstract: Respiratory syncytial (RS) virus is the main cause of severe respiratory infections in newborns and infants during the first year of life. In the recent years, search is under way for chemo- and immune replacement therapy preparations for etiotropic RS-infection therapy. Procedures have been developed to prepare immunoglobulins and Chigain preparations having a target-oriented action. They were clinically tested. There was a positive dynamics in the clinical manifestations of the disease and a positive influence on immunological parameters in children.
authors.forename: E E
authors.initials: EE
authors.lastname: Pokrovskaia
authors.forename: L V
authors.initials: LV
authors.lastname: Osidak
authors.forename: I I
authors.initials: II
authors.lastname: Maslennikova
authors.forename: N A
authors.initials: NA
authors.lastname: Markevich
authors.forename: M V
authors.initials: MV
authors.lastname: Osipova
authors.forename: V P
authors.initials: VP
authors.lastname: Drinevskiĭ
authors.forename: A V
authors.initials: AV
authors.lastname: Ispolatova
mesh_terms: D000914:Antibodies, Viral / Q000032:analysis; D001685:Biological Factors / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003126:Colostrum; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use*; D007167:Immunotherapy; D007223:Infant; D007231:Infant, Newborn; D018357:Respiratory Syncytial Virus Infections / Q000276:immunology / Q000628:therapy* / Q000821:virology; D012136:Respiratory Syncytial Viruses / Q000276:immunology
chemical_list: D000914:Antibodies, Viral; D001685:Biological Factors; D007136:Immunoglobulins; C085744:chigain
vernacular_title: Immunozamestitel'naia terapiia RS-infektsii.